VISTAGEN THERAPEUTICS, INC. Payments to Acquire Productive Assets
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Payments to Acquire Productive Assets of $0 for the 12-month period ending 2024-03-31, per its 10-K filed 2024-06-11.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireProductiveAssets · last filed 2024-06-11
- VISTAGEN THERAPEUTICS, INC. payments to acquire productive assets for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- VISTAGEN THERAPEUTICS, INC. payments to acquire productive assets for fiscal 2023 was $528.00K.
- VISTAGEN THERAPEUTICS, INC. payments to acquire productive assets for fiscal 2022 was $0.00.
| Period end | Payments to Acquire Productive Assets 12 month | Payments to Acquire Productive Assets 12 month as first filed |
|---|---|---|
| 2024-03-31 | $0.00 10-K · filed 2024-06-11 | |
| 2023-03-31 | $528.00K 10-K · filed 2024-06-11 | $528.30K 10-K · filed 2023-06-28 |
| 2022-03-31 | $0.00 10-K · filed 2023-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |